Parazelsus Ltd. Group Overview. January Registered office: Correspondence:

Transcription

1 Parazelsus Ltd Group Overview January 2013 Registered office: Parazelsus Limited 13/F, Grand Building 18 Connaught Road Central, Hong Kong Correspondence: Parazelsus Limited 6/F, Dreikönighaus Beethovenstrasse Zürich, Switzerland Tel Tel Fax

2 parazelsus ltd 1. Parazelsus is a group focused primarily on marketing, sales and distribution services to manufacturers of healthcare and medical products. 2. We are an independent, privately owned business. Our experience and track record is linked with the successful development of Zuellig Pharma over the past 25 years. 3. With our focus on emerging regions in Europe, Asia and Latin America, our standards are transparent, professional and MNC oriented. 4. We are lean, profitable and expect to reach an annualised group revenue / portfolio of US$ 500 million by the end of Our growth plan is supported by strategic partnerships such as the Godrej Group for South Asia. 6. Total number of employees in healthcare: 1,700

3 business structure Parazelsus group Investments Healthcare Marketing, Sales and Distribution Services Property Services Parazelsus Europe Parazelsus Orient Parazelsus Pazific Parazelsus Americaz Pezt Eastern Europe, Turkey Market entry projects Pakistan Pharmaceutical Marketing and Distribution Indonesia Pharmaceutical Marketing and Distribution Mexico Pharmaceutical Marketing ( ) Thailand Facility Services Pest Control, Hygiene, Cleaning India Pharmaceutical Contract Logistics and Distribution DPRK Pharma Manufacturing Distribution and Retail Latin America Market entry projects Ztrata Australia Body Corporate Services Bangladesh, Sri Lanka Market entry projects Australia, South East Asia Market entry projects

4 volume trend (at actual exchange rates)

5 india - pharmaceutical distribution Market entry August Established Parazelsus India Private Ltd. Strategic partnership with the Godrej Group. Pharmaceutical Distribution; focus on valueadding, specialty solutions. Cold Chain solution provider, targeting fast growing segment of biologicals. Covering top 20 locations across India. Validated by several MNCs. 3PL clients include Nicholas Piramal, J&J and Sanofi Pasteur. Parazelsus India Pvt Ltd Plant 14 P; Godrej Campus Pirojshanagar, Vikhroli Mumbai , India Tel Fax mail@parazelsus.co.in Web-based operating and CRM system. Developing single distribution solution model.

6 pakistan - pharmaceutical sales & distribution Market entry January Acquired distribution infrastructure of Novartis Pakistan. Full range of marketing and distribution services. 12 branches 855 personnel 35,000 active customers. Exclusive distributor for Novartis, Sandoz, Bayer, Greenstar, Schering Plough and finalising terms with additional 2 MNCs. Parazelsus Pakistan Pvt Ltd GSA House 95 East Wharf Road Karachi 75620, Pakistan Tel Fax mail@parazelsus.pk Centralised Oracle EBS IT system. ISO certification.

7 afghanistan medical sales & distribution Market entry May Acquired majority of Tradepoint Afghanistan. Range of marketing, sales and distribution services for medical and pharmaceuticals. 7 branches 50 personnel sub-distributors Key focus on tender management for medical equipment, medical supplies and pharmaceuticals. Parazelsus Afghanistan Ltd 1st street Charah-e-Gul-e-surkh Kolola Poshta, Kabul, Afghanistan Tel mail@parazelsus.af Full range of services as agent for foreign manufacturers of pharmaceuticals and medical products. Cold chain facility.

8 indonesia - pharmaceutical distribution Market entry July 2008 Acquired majority of PT DKSH Tunggal Well established, leading pharmaceutical distribution company; formed in 2006 as a joint venture between DKSH and Tunggal Sila Farma. Full range of marketing and distribution services 31 branches 760 personnel 25,000 active customers PT Parazelsus Indonesia 22 Menara Jamsostek, Jl Jend Gatot Subroto 38 Jakarta 12710, Indonesia Tel Fax mail@parazelsus.co.id 30 marketing and/or distribution agreements Centralised SAP system ISO certification

9 dprk - pharmaceuticals Market entry March Acquired majority of PyongSu J.V. Co. Ltd. Joint venture with Pyongyang Pharmaceuticals Factory. Pharmaceutical Manufacturing, Distribution and Retailing. Key service provider to WHO, IFRC and Unicef. 50 staff. Tablet and capsule manufacturing; 30 formulations; capacity of 300m tablets and capsules p.a. (1 shift) Pyongsu Pharma JV Co Ltd Pyongyang City Seongyo District, Daehungdong D.P.R. Korea Tel Fax mail@parazelsus.com 10 Pharmacies with a range of 250 Sku s. WHO-GMP certified.

10 mexico - pharmaceuticals Market entry August 2009 and partial exit Acquired majority of Lakeside de Mexico. Former subsidiary of Roche. Range of well established antibiotic products. Pharmaceutical marketing. Focus on life-cycle management. Expansion of product portfolio. Platform for introducing sales and distribution services. Expansion of geographic coverage in the Region. Lakeside de Mexico SA, de CV Prolongación Paseo de la Reforma Col. Paseo de las Lomas México, 01330, D.F México Tel Fax ext 110 mail@lakesidepharma.com Experienced management team.

11 senior management team Name / Role Peter Zuellig; Founder Head of Strategy Markus Haefeli Managing Director Reto Senn CEO; Parazelsus Indonesia Kaspar Kellerhals Director; Parazelsus Pakistan Bhuvan Asthana Head Operations; Parazelsus India Remy Lardinois CEO; Pyongsu Pharma; DPRK Previous experience Executive Director, The Zuellig Group Joint CEO, The Zuellig Group CEO Australia, The Zuellig Group New Zealand Various positions at TZG (joined in 1981) COO Sonnenhof; private hospital group, Switzerland CEO Pharma Industries, a division of TZG; Hong Kong CFO Zuellig Pharma; Hong Kong Procter & Gamble; Switzerland Regional Director of B. Braun for China and North Asia. Managing Director of Zuellig Pharma Vietnam. Commercial Director; DKSH Thailand Corporate Auditor; Novartis VP Operations of Anugerah Pharmindo Lestari in Indonesia. From 1996 till 2010 he worked for Zuellig Pharma in Malaysia, Hong Kong, Indonesia and the Philippines. Prior to his joining Zuellig Pharma he was Logistics and IT Manager at Danzas Travel in Switzerland. Manager Contract Logistics, UTi Worldwide (India) Pvt. Ltd. responsible for business development, warehouse operation and primary and secondary distribution for various multinational clients. Business Development Manager with Hellmann Worldwide Logistics in South Korea and 6 years in mainland China, various industries. Degree in Chinese and Korean Studies from the University of London.

12 corporate information Board of Directors Company Secretary Registered Office Mr. Peter Zuellig; Founder Mr. Markus Haefeli; Managing Director Charles Yeung Clement Lam Liu & Yip 13th Floor, Grand Building 18 Connaught Road Central; Hong Kong SAR 13th Floor, Grand Building 18 Connaught Road Central; Hong Kong SAR Correspondence 6/F, Dreikönighaus Phone Beethovenstrasse 32 Fax Zürich; Switzerland Auditor Legal Advisor Principal Bankers PricewaterhouseCoopers 8 Cross Street #17-00 PWC Building; Singapore Partner in charge: Mr. Rajandran Rajaratnam Kelvin Chia Partnership 6 Temasek Boulevard 29th Floor Suntec Tower Four Singapore Partner in charge: Mr. Kelvin Chia UBS AG; Switzerland

13 parazelsus Limited is an independent, pro-active investment and management group, founded by Peter Zuellig in The team at parazelsus includes industry and financial experts for its key investment areas - not alchemists. However, parazelsus understands very well how to generate value in the healthcare sector through an unconventional approach.